Perspective study on pamidronate in stage I multiple myeloma

Hematol J. 2003;4(6):459-60. doi: 10.1038/sj.thj.6200311.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Controlled Clinical Trial
  • Letter
  • Multicenter Study

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Diphosphonates / therapeutic use*
  • Humans
  • Multiple Myeloma / drug therapy*
  • Multiple Myeloma / mortality
  • Multiple Myeloma / pathology
  • Neoplasm Staging
  • Pamidronate
  • Survival Analysis

Substances

  • Antineoplastic Agents
  • Diphosphonates
  • Pamidronate